MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.590
-0.140 (-8.09%)
At close: Oct 30, 2026, 4:00 PM EDT
1.560
-0.030 (-1.89%)
After-hours: Oct 30, 2026, 7:30 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $164.1 million as of October 30, 2026. It is the 21,788th most valuable company in the world and the 3,727th biggest in the United States. Its market cap has increased by 1.94% in one year.
Market Cap
164.10M
Enterprise Value
75.66M
1-Year Change
1.94%
Global Rank
Country Rank
#3,727 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $164.10M, a decrease of -81.71%. That is a compound annual growth rate of -27.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 164.10M | -0.75% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 14.96% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 240.36M |
| Standard BioTools | 239.47M |
| TriSalus Life Sciences | 227.83M |
| Electromed | 224.08M |
| RxSight | 202.56M |
| Inogen | 182.05M |
| Neuronetics | 171.44M |
| Quanterix | 137.39M |